VOLVER AL LISTADO DE PUBLICACIONES

Pre-launch activities by generic companies: patent law and unfair competition

15 de marzo, 2013

Background
The defendant had obtained marketing authorisations for the commercialisation of its drugs more than three years before the expiry date of the supplementary protection certificate (SPC) protecting the relevant active ingredient. The defendant not only obtained these marketing authorisations, but also applied for and obtained price fixation for its drugs and requested their inclusion in the National Health System.



Ver todas

Publicaciones relacionadas

VOLVER AL LISTADO DE PUBLICACIONES